Dimension Data and Cisco Take Anti-Poaching Technology into Africa
Global technology giants, Dimension Data and Cisco, today announced that they are expanding their anti-poaching Connected Conservation programme into Zambia, Kenya, and Mozambique to continue protecting rhino, as well as help fight the war on the startling numbers of African savanna elephant being poached. This move follows a successful pilot which saw the two companies install some of the world’s most sophisticated technology in a private game reserve located next to the world-renowned Kruger National Park in South Africa.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180508006383/en/
Organised crime levels of elephant tusks (Photo: Dimension Data)
Since the Connected Conservation technology was deployed in the private reserve in November 2015, the number of rhino poaching incidents has been reduced by 96%. In 2017, no rhino in the reserve were poached.
Every day, hundreds of suppliers and contractors, staff, security personnel, and tourists enter and exit game reserves and parks around the world. The human activity in these environments is often not monitored because the reserve is in a remote location with basic IT infrastructure and access control, manual security processes, and very limited communication.
“Many organisations have committed to protecting animals through various reactive initiatives, such as dehorning, or inserting sensors in the horn and under the subcutaneous layer of skin, explained Dimension Data Group Executive, Bruce Watson. “However, the problem with reactive initiatives is that by the time the reserve rangers reach the animal, it has been killed and the rhino horn or elephant tusks have been hacked off.”
With the Connected Conservation model, the technology is designed to proactively protect the land against humans. The animals are not touched, and are left to roam freely while a ‘layered’ effect of sophisticated technology, people and gadgets protect them.”
Cisco and Dimension Data’s vision is to replicate the solution in South Africa, Africa, and globally to protect all forms of endangered species including lion, pangolin, elephant, tigers in India and Asia, as well as sharks and sea rays in the ocean. The next project is already underway in an unnamed park in Zambia. This will be followed by Kenya and then Mozambique with a strong focus on protecting elephant.
According to a 2016 ¹Great Elephant Census (GEC) carried out by the Seattle-based Vulcan Inc, which is the engine behind philanthropist and Microsoft co-founder Paul G. Allen's network of organisations and initiatives, the savanna elephant population declined by 30% between 2007 and 2014, which equates to 144,000 elephants. The current rate of decline is 8% per year, primarily due to poaching. In Zambia, the elephant count was 21,758, with an 85%² carcass ratio in Siomi Ngwezi National Park, 3% for the rest of Zambia, and substantial declines along the Zambezi River.
The research also revealed that between 4,000 and 6,000 poachers were from households situated in the Game Management Areas (GMAs). This includes fisherman crossing large expanses of water into the game park.
A control room for Zambia’s special marine unit is being built to monitor operations across the lake and in the park, and a second marine unit powerboat will be deployed to assist with intercepts before poachers get to the animals.
Other equipment being deployed in Zambia includes:
- Fixed thermal cameras mounted on radio masts which creates a permanent, virtual barrier on the park’s perimeter. The cameras which scan the park’s entry and exit gates are controlled by operators located in the control room.
- CCTV analytics will be deployed to create a virtual trip-line that automatically detects the movement of fishermen and boats on the lake. Over time, park officials will be able to analyse the data and build a pattern of movement, as well as alert operators when there’s night-time movement across the barrier.
- Outdoor Wi-Fi will also be mounted on the radio masts so that handheld devices and thermal cameras used by the rangers and security teams can be viewed and shared, and staff on the ground will be able to connect and communicate without their conversations being intercepted by poachers.
“We’re also working with the Zambian local authorities and the fishing community to create a centralised digital fishing permit system that will monitor individuals who pose as fisherman but are actually poachers,” Watson said.
Cisco Senior Vice President and Chief Marketing Officer, Karen Walker, said, “More than ever before, technology has given us the ability to change the world – not tomorrow, not someday, but now. At Cisco, we’re dedicated to making a difference by connecting the world and protecting the oldest and most vulnerable animals with some of the newest connectivity technology.
“Working closely with Dimension Data, we’ve established a secure, reliable network that operates 24 hours daily across game reserves in South Africa and Africa. We are extremely proud to be part of the expansion of Connected Conservation into Africa, to save more endangered species.”
Watson added: “In partnership with Cisco, our vision is to eliminate all forms of poaching globally through continuous innovation in technology to protect more vulnerable species in more countries.”
¹The Great Elephant Census was a collaboration between Microsoft co-founder, Paul G. Allen’s Vulcan Inc – and Elephants Without Borders , African Parks , the Frankfurt Zoological Society , the Wildlife Conservation Society , the Nature Conservancy , the IUCN African Elephant Specialist Group , and Save the Elephants
Hilary King, +27824149623
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Ultra-Low Power Lattice sensAI Leads Mass Market Enablement of Artificial Intelligence in Edge Devices21.5.2018 15:00 | Tiedote
Lattice Semiconductor Corporation (NASDAQ: LSCC) today unveiled Lattice sensAI™ – a complete technology stack combining modular hardware kits, neural network IP cores, software tools, reference designs and custom design services – to accelerate integration of machine learning inferencing into broad market IoT applications. With solutions optimized for ultra-low power consumption (under 1 mW–1 W), small package size (5.5 mm2 –100 mm2), interface flexibility (MIPI® CSI-2, LVDS, GigE, etc.), and high-volume pricing (~$1-$10 USD), Lattice sensAI stack fast-tracks implementation of edge computing close to the source of data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005011/en/ (Graphic: Business Wire) “Lattice sensAI addresses the unmet need for flexible, low cost, ultra-low power AI silicon solutions suited for rapid deployment across a wide range of emerging, mass market IoT applications,” said Deepak Boppana, senior
NioCorp Awards Contract to Rockwell Automation on Groundbreaking Critical Minerals, Mining and Processing Facility in Nebraska21.5.2018 15:00 | Tiedote
NioCorp Developments Ltd. (TSX: NB, OTCQX: NIOBF), a developer of superalloy metals, has awarded a major contract to Rockwell Automation (NYSE: ROK) to engineer, design and procure process automation and instrumentation for NioCorp’s proposed critical minerals, mining and processing facility in Elk Creek, Nebraska. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005228/en/ Three superalloy metals – niobium, scandium and titanium – are expected to be produced by the facility as early as 2021. These critical materials are used in the aerospace, defense, automotive, clean energy, commercial aviation and mega-infrastructure sectors. Generally, these superalloys enable increased strength and lighter weight in transportation and other systems, leading to better fuel efficiency and lower greenhouse gas and other air emissions, according to NioCorp. “We selected Rockwell Automation and its partners to automate our process equip
Biosimilars could facilitate early access to life changing biological treatments for patients says Celltrion Healthcare21.5.2018 14:27 | Tiedote
At the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting in Baltimore, Celltrion Healthcare today advocated for healthcare systems to introduce biologics earlier in a patient’s treatment regimen in order to improve clinical outcomes. Several studies show that the early introduction of biologics can bring greater clinical benefit to patients.1,2,3,4,5,6 However, only a limited number of patients have access to biological treatment due to the high-cost of biologics and current reimbursement policies determined by pharmacoeconomic evaluations. Since the introduction of biosimilars, the overall cost of biological treatments has reduced in Europe, allowing an increased number of patients to access this important treatment option earlier in their course of treatment.7 Professor Jørgen Jahnsen said, “For the treatment of inflammatory bowel disease, biological treatments are proven to be the most efficacious medical therapy and their ea
Dole’s Joint Venture Recycling Company Celebrates 25 Years21.5.2018 14:00 | Tiedote
Dole Food Company announced today that Recyplast S.A., an innovative plastic recycling company based in Costa Rica and with joint ownership including a subsidiary of Dole Fresh Fruit, recently surpassed 25 years in its mission to dramatically reduce and reuse agricultural waste. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005160/en/ Raul Martinez (right), General Manager of Dole Standard Fruit de Costa Rica, receives a plaque from Jose Miguel Ramirez, General Manager of Recyplast, in recognition of the contribution of Dole's banana plantations in the correct handling, storage, and provision of field plastic waste. The plastic recycling facility pioneered the collection of field plastics after use in banana growing operations in Costa Rica. This reuse and recycling process includes reclamation of plastic bags that protect bananas from weather and insects, as well as the collection of plastic twine used to prop the ba
ViiV Healthcare Receives EU Marketing Authorisation for Juluca (dolutegravir/rilpivirine), the First 2-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV21.5.2018 13:11 | Tiedote
ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the European Commission has granted marketing authorisation for Juluca (dolutegravir 50mg/rilpivirine 25mg) for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor or integrase inhibitor.1 Juluca is a 2-drug regimen of dolutegravir (ViiV Healthcare), the most widely prescribed integrase inhibitor worldwide,2 and rilpivirine (Janssen Sciences Ireland UC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson).1 Deborah Waterhouse, CEO ViiV Healthcare said, “The European Commission Decision for Juluca is very positive news for people living with
Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-121.5.2018 13:06 | Tiedote
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission has granted marketing authorisation for JULUCA® (dolutegravir 50mg [ViiV Healthcare]/rilpivirine 25mg [Janssen Sciences Ireland UC]).1 ViiV Healthcare, as the marketing authorisation holder, will market dolutegravir/rilpivirine in all countries in the European Union and European Economic Area. Dolutegravir/rilpivirine is the first two-drug regimen, once-daily, single-pill for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase inhibitor (INI).1 “The European Commission Decision for dolutegravir/rilpivirine marks a significant milestone in our 25-year commitment to make HIV history,” said Brian Woo
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme